Levofloxacin Hydrochloride

盐酸左氧氟沙星

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLevofloxacin Hydrochloride
Drug Alias NameWeilisu
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Steroids
Mechanisms of ActionBacterial DNA gyrase inhibitors
TargetsBacterial DNA gyraseTopoisomerase II
Therapy Area/IndicationsCystic FibrosisRespiratory Tract InfectionsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsCystic FibrosisRespiratory Tract InfectionsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A